Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients.

In addition, fewer tocilizumab-treated patients required mechanical ventilation (10% in the SOC+T arm versus 15% the SOC arm), although this did not reach statistical significance (p = 0.18).

also in 111,027 other papers